Form 4: Director Rhoads Reports QuidelOrtho Stock Transactions

Ann D. Rhoads, a Director at QuidelOrtho Corp, reported transactions involving the release of restricted stock units and the acquisition of common stock.

Summary

• Director Ann D. Rhoads reported the release of 1,173 restricted stock units (RSUs) and 234 restricted stock units (premium) on May 22, 2026.
• These RSUs were previously reported and were released according to QuidelOrtho's deferred compensation program for non-employee directors.
• Following these transactions, Rhoads beneficially owns 16,194 shares of common stock directly, and an additional 234 shares directly, totaling 16,428 shares.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral filing, as it represents routine reporting of restricted stock unit releases and does not indicate a change in the director's overall beneficial ownership or a new strategic initiative.

Positives

• Director Ann D. Rhoads's beneficial ownership of QuidelOrtho common stock remains significant at 16,428 shares after the reported transactions.
• The release of RSUs indicates the fulfillment of prior compensation awards to a key executive.

Future Outlook

No specific future outlook or guidance is provided in this Form 4 filing, which primarily reports past transactions.

Industry Context

StockSavvy.ai notes that Form 4 filings are standard disclosures for insider transactions, providing transparency into the holdings and activities of company directors and officers. These filings are crucial for investors monitoring potential shifts in insider confidence or compensation structures within the biotechnology and diagnostics sector.

Stakeholder Impact

• Shareholders gain transparency into director compensation and stock holdings.
• Employees may observe the fulfillment of executive compensation plans.

Key Dates

Keywords

Form 4, SEC Filing, Insider Trading, Stock Transaction, Restricted Stock Units, Beneficial Ownership, Director, QuidelOrtho Corp, QDEL